Health-related quality of life varies in different respiratory disorders: a multi-case control population based study.
Allergy
Asthma
COPD
Clinical epidemiology
Quality of life
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
07 Feb 2019
07 Feb 2019
Historique:
received:
19
01
2018
accepted:
29
01
2019
entrez:
9
2
2019
pubmed:
9
2
2019
medline:
8
6
2019
Statut:
epublish
Résumé
Health-related quality of life (HRQL) in respiratory diseases has been generally investigated in clinical settings, focusing on a single disorder. In this study on a general population sample, we assessed the relationship between HRQL and several respiratory diseases studied simultaneously (COPD, current (CA) and past (PA) asthma, allergic (AR) and non-allergic (NAR) rhinitis and chronic bronchitis (CB). Controls (n = 328) and cases of NAR (n = 95), AR (n = 163), CB (n = 48), CA (n = 224), PA (n = 126) and COPD (n = 28) were recruited in the centre of Verona in the frame of the Italian multi-case control GEIRD (Gene Environment Interactions in Respiratory Diseases) study; HRQL was measured through the SF-36 questionnaire. The relationships between HRQL (in terms of Physical (PCS) and Mental Component Scores (MCS)), respiratory diseases, and covariates were evaluated. With respect to controls, the adjusted PCS median score was worse in subjects suffering from current asthma (- 1.7; 95%CI:-2.8;-0.6), CB (- 3.8; 95%CI:-5.7;-1.9), and COPD (- 5.6; 95%CI:-8.1;-3.1). MCS was worse in current asthmatics (- 2.2; 95%CI:-4.1;-0.3), CB (- 5.5; 95%CI:-8.7;-2.2), and COPD cases (- 4.6; 95%CI:-8.8;-0.5) as well. To our knowledge, this is the first study in the general population that analyzed HRQL performing a simultaneous comparison of HRLQ in several respiratory disorders. We found that subjects suffering from COPD, CA, and CB had the poorest HRQL. Clinicians should carefully consider the possible impact of respiratory disorders as CB and not only that of CA and COPD.
Sections du résumé
BACKGROUND AND OBJECTIVE
OBJECTIVE
Health-related quality of life (HRQL) in respiratory diseases has been generally investigated in clinical settings, focusing on a single disorder. In this study on a general population sample, we assessed the relationship between HRQL and several respiratory diseases studied simultaneously (COPD, current (CA) and past (PA) asthma, allergic (AR) and non-allergic (NAR) rhinitis and chronic bronchitis (CB).
METHODS
METHODS
Controls (n = 328) and cases of NAR (n = 95), AR (n = 163), CB (n = 48), CA (n = 224), PA (n = 126) and COPD (n = 28) were recruited in the centre of Verona in the frame of the Italian multi-case control GEIRD (Gene Environment Interactions in Respiratory Diseases) study; HRQL was measured through the SF-36 questionnaire. The relationships between HRQL (in terms of Physical (PCS) and Mental Component Scores (MCS)), respiratory diseases, and covariates were evaluated.
RESULTS
RESULTS
With respect to controls, the adjusted PCS median score was worse in subjects suffering from current asthma (- 1.7; 95%CI:-2.8;-0.6), CB (- 3.8; 95%CI:-5.7;-1.9), and COPD (- 5.6; 95%CI:-8.1;-3.1). MCS was worse in current asthmatics (- 2.2; 95%CI:-4.1;-0.3), CB (- 5.5; 95%CI:-8.7;-2.2), and COPD cases (- 4.6; 95%CI:-8.8;-0.5) as well.
CONCLUSIONS
CONCLUSIONS
To our knowledge, this is the first study in the general population that analyzed HRQL performing a simultaneous comparison of HRLQ in several respiratory disorders. We found that subjects suffering from COPD, CA, and CB had the poorest HRQL. Clinicians should carefully consider the possible impact of respiratory disorders as CB and not only that of CA and COPD.
Identifiants
pubmed: 30732605
doi: 10.1186/s12890-019-0796-8
pii: 10.1186/s12890-019-0796-8
pmc: PMC6367788
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
32Références
Clin Exp Allergy. 2002 Oct;32(10):1405-12
pubmed: 12372117
Ann Allergy Asthma Immunol. 2000 Apr;84(4):403-10
pubmed: 10795648
Am J Epidemiol. 1993 Nov 15;138(10):840-8
pubmed: 8237972
Chest. 2007 Jun;131(6):1890-7
pubmed: 17505046
BMC Palliat Care. 2011 Oct 17;10:15
pubmed: 22004467
Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 2):S77-121
pubmed: 7582322
Chron Respir Dis. 2010;7(4):207-15
pubmed: 21084545
Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):371-5
pubmed: 8306032
Eur Respir J. 1994 Dec;7(12):2139-45
pubmed: 7713194
Allergy. 2008 May;63(5):547-54
pubmed: 18394129
Psychosom Med. 2002 Jul-Aug;64(4):684-91
pubmed: 12140359
BMC Public Health. 2010 Sep 09;10:546
pubmed: 20828414
Eur Respir J. 2008 Jan;31(1):143-78
pubmed: 18166595
Heart Lung. 1996 May-Jun;25(3):212-24
pubmed: 8635922
J Health Soc Behav. 1997 Mar;38(1):21-37
pubmed: 9097506
J Investig Allergol Clin Immunol. 2002;12(3):204-10
pubmed: 12530120
Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1391-6
pubmed: 11029350
Int Arch Allergy Immunol. 2013;161(2):181-8
pubmed: 23363736
BMJ. 1992 Jul 18;305(6846):160-4
pubmed: 1285753
Allergy. 2008 Apr;63 Suppl 86:8-160
pubmed: 18331513
J Palliat Med. 2010 Sep;13(9):1109-18
pubmed: 20836635
Qual Life Res. 2004 Mar;13(2):283-98
pubmed: 15085901
Qual Life Res. 2011 Dec;20(10):1679-88
pubmed: 21442430
Respir Med. 2014 Mar;108(3):491-9
pubmed: 24280543
Chronic Dis Can. 2009;29(3):108-16
pubmed: 19527569
J Allergy Clin Immunol. 2001 Nov;108(5 Suppl):S147-334
pubmed: 11707753
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Oman Med J. 2011 Nov;26(6):416-20
pubmed: 22253950
Clin Exp Allergy. 2002 Sep;32(9):1310-5
pubmed: 12220469
Arch Intern Med. 1998 Mar 9;158(5):457-64
pubmed: 9508223
Psychosomatics. 1999 Nov-Dec;40(6):491-6
pubmed: 10581977
Thorax. 2000 Dec;55(12):1000-6
pubmed: 11083884
Int Arch Allergy Immunol. 2010;152(3):255-63
pubmed: 20150743
Can J Public Health. 2004 Sep-Oct;95(5):387-91
pubmed: 15490932
Chest. 2003 Jan;123(1):119-27
pubmed: 12527612
Curr Opin Pulm Med. 2012 Mar;18(2):97-103
pubmed: 22262138